Pfizer Inc (PFE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Sales | 11,263,000 | 11,452,000 | 13,091,000 | 11,396,000 | 12,831,000 |
| Cost of Goods | 1,611,000 | 1,762,000 | 2,191,000 | 1,205,000 | 1,640,000 |
| Gross Profit | 9,652,000 | 9,690,000 | 10,900,000 | 10,191,000 | 11,191,000 |
| Operating Expenses | 7,791,000 | 6,976,000 | 6,952,000 | 6,631,000 | 6,957,000 |
| Operating Income | 1,861,000 | 2,714,000 | 3,948,000 | 3,560,000 | 4,234,000 |
| Other Income | 151,000 | 198,000 | -1,038,000 | -665,000 | -283,000 |
| Pre-tax Income | 2,012,000 | 2,912,000 | 2,910,000 | 2,895,000 | 3,951,000 |
| Income Tax | 530,000 | -464,000 | 2,635,000 | 419,000 | 650,000 |
| Net Income Continuous | 1,479,000 | 3,375,000 | 272,000 | 2,476,000 | 3,298,000 |
| Net Income Discontinuous | 110,000 | 88,000 | 29,000 | 350,000 | 43,000 |
| Net Income | $1,589,000 | $3,463,000 | $301,000 | $2,826,000 | $3,341,000 |
| EPS Basic Total Ops | 0.22 | 0.47 | 0.04 | 0.37 | 0.45 |
| EPS Basic Continuous Ops | 0.20 | 0.46 | 0.04 | 0.32 | 0.44 |
| EPS Basic Discontinuous Ops | 0.02 | 0.01 | 0.00 | 0.05 | 0.01 |
| EPS Diluted Total Ops | 0.22 | 0.47 | 0.04 | 0.37 | 0.44 |
| EPS Diluted Continuous Ops | 0.20 | 0.46 | 0.04 | 0.32 | 0.43 |
| EPS Diluted Discontinuous Ops | 0.02 | 0.01 | 0.00 | 0.05 | 0.01 |
| EBITDA(a) | $3,228,000 | $4,124,000 | $5,314,000 | $4,871,000 | $5,499,000 |